QNCX

Quince Therapeutics Inc
0.97
-0.0094 (-0.96%)
0.97
Volume 443
Bid Price 0.985
Ask Price 1.00
News -
Day High

Low
0.5401

52 Week Range

High
6.80

Day Low
Company Name Stock Ticker Symbol Market Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0094 -0.96% 0.97 04:41:13
Open Price Low Price High Price Close Price Prev Close
0.9794
Trades Volume Avg Volume 52 Week Range
3 443 - 0.5401 - 6.80
Last Trade Time Type Quantity Stock Price Currency
04:19:38 formt 342 $ 0.97 USD

Period:

Draw Mode:

Quince Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 35.05M 36.13M 25.47M $ - $ - -3.03 -0.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.64k 6.90%

more financials information »

Quince Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QNCX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.911.090.910.9951498462,8430.066.59%
1 Month0.74381.470.7151.063,864,2220.226230.41%
3 Months0.73171.470.54011.021,433,8340.238332.57%
6 Months2.182.71710.54011.08770,494-1.21-55.5%
1 Year5.506.800.54012.07620,315-4.53-82.36%
3 Years50.72121.980.540117.60544,021-49.75-98.09%
5 Years20.00121.980.540118.70457,179-19.03-95.15%

Quince Therapeutics Description

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.